Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta/delta isoform' and Ligand = 'BDBM255824'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta/delta isoform (Homo sapiens (Human))	BDBM255824 (5-{3-[1-(4-amino-5-oxopyrido[2,3-d]pyrimidin-8(5H)...) Show SMILES CNC(=O)c1ccc(cn1)-c1c(C)c(Cl)cc(C(C)n2ccc(=O)c3c(N)ncnc23)c1OC Show InChI InChI=1S/C24H23ClN6O3/c1-12-16(25)9-15(13(2)31-8-7-18(32)20-22(26)29-11-30-23(20)31)21(34-4)19(12)14-5-6-17(28-10-14)24(33)27-3/h5-11,13H,1-4H3,(H,27,33)(H2,26,29,30)	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<10	n/a	n/a	n/a	n/a	6.7	25
Incyte Holdings Corporation; Incyte Corporation US Patent					Assay Description Lipid kinase substrate, phosphoinositol-4,5-bisphosphate (PIP2), are purchased from Echelon Biosciences (Salt Lake City, Utah). PI3K isoforms α,...				US Patent US9707233 (2017) BindingDB Entry DOI: 10.7270/Q2S46V0R
					More data for this Ligand-Target Pair